RTI International, 3040 E. Cornwallis Road, Research Triangle Park, 27709, NC, USA.
RTI International, 3040 E. Cornwallis Road, Research Triangle Park, 27709, NC, USA.
Neurotoxicology. 2019 Jul;73:161-167. doi: 10.1016/j.neuro.2019.04.002. Epub 2019 Apr 3.
A recent push to provide more translationally relevant preclinical models for examination of pharmacological mechanisms underlying inhaled substances of abuse has resulted in the development of equipment and methods that allows exposure of freely moving rodents to aerosolized psychoactive drugs. In the present study, synthetic cannabinoids (CP55,940, AB-CHMINACA, and AMB-FUBINACA) were administered intraperitoneally (i.p.) or aerosolized via a modified electronic cigarette device. Subsequently, the compounds were evaluated in adult male and female C57/Bl6 mice trained to discriminate i.p. 5.6 mg/kg Δ-tetrahydrocannabinol (THC) for food reinforcement. When administered i.p., THC and AB-CHMINACA were equally potent at producing THC-like effects in both sexes, but CP55,940 and AMB-FUBINACA were more potent in males. Upon aerosol exposure, all compounds continued to produce THC-like effects in both sexes, with AMB-FUBINACA remaining the most potent. In contrast, aerosolized CP55,940 showed substantial decreases in potency in both sexes. Aerosolized nicotine did not substitute for THC in either sex. In females, aerosolized cumyl-4CN-BINACA produced concentration-dependent increases in responding on the THC-associated nosepoke. In addition, the effects of an active concentration of AMB-FUBINACA were reversed by rimonabant, suggesting CB receptor mediation. These results show that synthetic cannabinoids produce THC-like effects when injected i.p. or after aerosolization. This study adds to a growing literature suggesting that evaluation of abuse liability of substances via aerosol exposure is feasible and may provide a translationally relevant method that allows for investigation of factors important to the abuse of drugs which humans typically smoke or vape.
最近,人们努力为研究滥用吸入性物质的药理学机制提供更具转化相关性的临床前模型,这导致了可使自由活动的啮齿动物暴露于雾化精神活性药物的设备和方法的发展。在本研究中,合成大麻素(CP55,940、AB-CHMINACA 和 AMB-FUBINACA)通过腹膜内(i.p.)给药或通过改良的电子烟装置雾化给药。随后,在接受过腹腔内 5.6mg/kg Δ-四氢大麻酚(THC)食物强化训练的成年雄性和雌性 C57/Bl6 小鼠中评估了这些化合物。当腹腔内给药时,THC 和 AB-CHMINACA 在两性中产生类似 THC 的作用的效力相当,但 CP55,940 和 AMB-FUBINACA 在雄性中更有效。在雾化暴露时,所有化合物继续在两性中产生类似 THC 的作用,而 AMB-FUBINACA 仍然最有效。相比之下,雾化 CP55,940 在两性中的效力都大大降低。雾化尼古丁在两性中均不能替代 THC。在雌性中,雾化 cumyl-4CN-BINACA 导致与 THC 相关的鼻触反应呈浓度依赖性增加。此外,活性浓度的 AMB-FUBINACA 的作用被利莫那班逆转,表明 CB 受体介导。这些结果表明,合成大麻素在腹腔内注射或雾化后产生类似 THC 的作用。本研究增加了越来越多的文献表明,通过雾化暴露评估物质的滥用倾向是可行的,并且可能提供一种具有转化相关性的方法,可用于研究对人类通常吸烟或蒸气的药物滥用很重要的因素。